Researchers are presenting studies reporting on the effectiveness of new therapies for chronic hepatitis C virus, as well as findings from an age-based risk assessment and screening intervention for hepatitis C among Baby Boomers, patients aged 50-65, who saw a gastroenterologist for routine colon cancer screening.